Press Release

<< Back
Printer Friendly Version View printer-friendly version
Depomed to Present at Healthcare Conferences in March

NEWARK, Calif., March 06, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that senior management will present at the following healthcare conferences during the month of March.

29th Annual ROTH Conference

Date: Monday, March 13, 2017
Time: 3:00 p.m. PDT
Location: Dana Point, California

Oppenheimer 27th Annual Healthcare Conference

Date: Tuesday, March 21, 2017
Time: 8:30 a.m. EDT
Location: New York, New York

These presentations will be webcast live and may be accessed via the Investor Relations page of the Depomed website at www.depomed.com.  A recording of these events will be archived for 30 days on the company's website.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit www.depomed.com.

Investor Contact:

Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000
ckeenan@depomed.com

Primary Logo

Depomed, Inc